TISSUE & FFPE COHORT COLLECTIONS
Prostate cancer tissue microarrays & FFPE blocks
Compare prostate cancer arrays by disease context, Gleason information and tissue composition, including selected hormone-refractory and progression collections. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Prostate cancer arrays (7)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
Hormone refractory prostate cancers with Gleason scores (TA1843)
- Approx. cores
- 40
- Approx. donors
- 20
- Core diameter
- 1mm
- Clinical follow-up
- Not listed
- Molecular data
- Not listed
HRPC with follow up & sequential PSA data (TA3029)
- Approx. cores
- 45
- Approx. donors
- 45
- Core diameter
- 1mm
- Clinical follow-up
- Available
- Molecular data
- Available
Prostate ADC with histopath data, Gleason scores 6-10, includes hormone refractory (TA1930
- Approx. cores
- 140
- Approx. donors
- 140
- Core diameter
- 1mm
- Clinical follow-up
- Not listed
- Molecular data
- Not listed
Prostate cancer primary & matched nodal mets with histopath data (TA3069)
- Approx. cores
- 48
- Approx. donors
- 48
- Core diameter
- 1mm
- Clinical follow-up
- Not listed
- Molecular data
- Not listed
Prostate cancer progression array with follow up data, includes normal, PIN, Gleason 6-10 (TA2573)
- Approx. cores
- 150
- Approx. donors
- 75
- Core diameter
- 1mm
- Clinical follow-up
- Available
- Molecular data
- Not listed
RNAscope prequalified metastatic HRPC/CRPC pre and post treatment (not donor matched) with follow up data (TA4330)
- Approx. cores
- 52
- Approx. donors
- 52
- Core diameter
- 1mm
- Clinical follow-up
- Available
- Molecular data
- Not listed
RNAscope prequalified prostate cancer (III/IV) TMA, includes HRPC, Gleason 6-10 with histopath data (TA3123)
- Approx. cores
- 112
- Approx. donors
- 56
- Core diameter
- 1mm
- Clinical follow-up
- Not listed
- Molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Prostate cancer FFPE blocks for your study
Prostate FFPE profiles include metastatic disease, castration-resistant disease, PSMA-positive mCRPC and neuroendocrine prostate carcinoma.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
Explore Prostate cancer FFPE cohort profiles
Collection features
- Advanced disease (III/IV)
- Longitudinal data
- Pre / post standard-of-care treatment
Features vary by profile and donor; confirm the required coverage for your study.
Metastatic prostate cancer
Inquire about this cohortMetastatic castration-resistant prostate cancer (mCRPC)
Inquire about this cohortmCRPC with prior taxane exposure
Inquire about this cohortPSMA-positive mCRPC
Inquire about this cohortNeuroendocrine prostate carcinoma
Inquire about this cohortProfiles describe documented collections, not live inventory. Features vary by profile and donor. Pre/post treatment collections are not necessarily donor-matched; availability and required coverage are confirmed for your study.
SELECTING YOUR ARRAY
Selecting prostate cancer tissue for your study
Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.
Hormone-Refractory Prostate Cancer TMA
This hormone-refractory prostate cancer tissue microarray is listed with Gleason scores. The hormone-refractory setting and grading information distinguish it from prostate arrays defined only by histopathology.
Prostate Cancer TMA: Matched Nodal Metastases
This prostate cancer tissue microarray includes primary tumors and matched nodal metastases with histopathology data. Nodal tissue is the specified metastatic component of this collection.
RNAscope HRPC/CRPC TMA: Pre/Post Treatment
This RNAscope-prequalified metastatic HRPC/CRPC tissue microarray includes pre- and post-treatment samples with follow-up data. The pre/post groups are not donor matched.






